➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Boehringer Ingelheim
Mallinckrodt
Baxter
Merck

Last Updated: August 4, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TWINJECT 0.3

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for TWINJECT 0.3

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02571283 ↗ Peri-articular Injection Utilizing a Pain Cocktail With and Without Exparel Withdrawn Arthroplasty Foundation, Inc. Phase 4 2015-10-01 A prospective, randomized control study will be conducted to compare postoperative pain control in a series of patients treated with either: 1. a local cocktail. 2. a local cocktail plus Exparel. 3. marcaine plus Exparel prior to wound closure following knee arthroplasty.
NCT02571283 ↗ Peri-articular Injection Utilizing a Pain Cocktail With and Without Exparel Withdrawn University of Louisville Phase 4 2015-10-01 A prospective, randomized control study will be conducted to compare postoperative pain control in a series of patients treated with either: 1. a local cocktail. 2. a local cocktail plus Exparel. 3. marcaine plus Exparel prior to wound closure following knee arthroplasty.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for TWINJECT 0.3

Condition Name

Condition Name for TWINJECT 0.3
Intervention Trials
Total Knee Arthroplasty 1
Pain Management 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for TWINJECT 0.3
Intervention Trials
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for TWINJECT 0.3

Clinical Trial Phase

Clinical Trial Phase for TWINJECT 0.3
Clinical Trial Phase Trials
Phase 4 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for TWINJECT 0.3
Clinical Trial Phase Trials
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TWINJECT 0.3

Sponsor Name

Sponsor Name for TWINJECT 0.3
Sponsor Trials
University of Louisville 1
Arthroplasty Foundation, Inc. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for TWINJECT 0.3
Sponsor Trials
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Baxter
AstraZeneca
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.